Eli Lilly's valuation has been driven higher by investor excitement around GLP-1 drugs, leaving other drugmakers languishing.
Jan 21 (Reuters) - Merck & Co unit MSD and the Coalition for Epidemic Preparedness Innovations said on Wednesday they have ...
Jan 21 (Reuters) - Merck and the Coalition for Epidemic Preparedness Innovations said on Wednesday they have partnered on a ...
AbbVie extended the patent life on Humira for years, enough time to more than replace the sales. Now Merck and Bristol Myers ...
Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...
Moderna and Merck’s cancer vaccine reduced the risk of relapse or death for melanoma patients, five-year data from a Phase 2b ...
By Kamal Choudhury and Mariam Sunny Jan 20 (Reuters) - Moderna and Merck said on Tuesday their experimental personalized ...
A personalized cancer treatment developed by Moderna Inc. and Merck & Co. helped prevent the recurrence of high-risk skin ...
Jan 20 () - Moderna and Merck said on Tuesday their experimental vaccine for a serious type of skin cancer, used in ...
The latest update to the Merck stock story centers on a revised price target, reflecting how analysts are reassessing the ...
BofA's US 1 list includes Merck, Apple, Nvidia, Spotify, Goldman Sachs, Walmart, and others, with detailed ratings and sector ...
Merck & Co., Inc. (NYSE:MRK) is included in our list of the 10 Goldman Sachs undervalued stocks to invest in. As of January ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results